Pregnancy Outcome Following Gestational Exposure To Azithromycin

Agreed , but my point was merely to illustrate the double standard at play here. The remdesivir trial was also under-powered to demonstrate a mortality benefit in the pre-specified statistical analysis. The mortality benefit claims here are based on post-hoc analysis , and mainly focused on a single subgroup , both practices which are normally… Continue reading Pregnancy Outcome Following Gestational Exposure To Azithromycin